🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
This is a multicenter, open-label Phase I/II clinical study to evaluate the...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-07-22
Trial ID
NCT07083323
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-05-01
Trial ID
NCT04863079
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
GSK2118436 is an orally administered, potent and selective small molecule B...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-03
Trial ID
NCT01340846
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-10
Trial ID
NCT00100997
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The investigators plan to carry out a phase II, open-label, single-arm clin...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Start Date
2023-11-01
Trial ID
NCT05891561
Treatments Being Tested
This 2-arm, multi-center, open-label, parallel-group phase II trial will as...
Status
Completed
Location
Managadze National Center of Urology
Start Date
2021-01-20
Trial ID
NCT04733040
Treatments Being Tested